Rheumatology Advisor


lupus of the cheek

Anifrolumab Superior to Placebo in Moderate to Severe Systemic Lupus Erythematosus

The following article is a part of conference coverage from the 2019 American College of Rheumatology/The Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, being held in Atlanta, Georgia. The team at Rheumatology Advisor will be reporting on the latest news and research conducted by leading experts in rheumatology. Check back for more from the 2019…

Next post in ACR 2019